Shubham Genetics Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 31-05-2024
- Paid Up Capital ₹ 0.10 M
as on 31-05-2024
- Company Age 12 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.50 M
as on 31-05-2024
- Revenue 0.27%
(FY 2017)
- Profit -17.60%
(FY 2017)
- Ebitda 277.48%
(FY 2017)
- Net Worth 9.87%
(FY 2017)
- Total Assets -39.51%
(FY 2017)
About Shubham Genetics
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.50 M.
Rekha Dhote and Sudhir Dhote serve as directors at the Company.
- CIN/LLPIN
U74900MH2012PTC233785
- Company No.
233785
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Jul 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media
What products or services does Shubham Genetics Private Limited offer?
Shubham Genetics Private Limited offers a wide range of products and services, including Fertilizers and Soil Additives, Micronutrient Fertilizers, Bulk Bags & Sacks, Jumbo Bags, Nutraceuticals & Dietary Supplements, Mineral Supplement, Animal Treatment Services, Veterinary Clinic, Buffalo, Antibacterial Drugs.
Who are the key members and board of directors at Shubham Genetics?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rekha Dhote  | Director | 25-Jul-2012 | Current |
| Sudhir Dhote | Director | 25-Jul-2012 | Current |
Financial Performance of Shubham Genetics.
Shubham Genetics Private Limited, for the financial year ended 2017, experienced modest growth in revenue, with a 0.27% increase. The company also saw a substantial fall in profitability, with a 17.6% decrease in profit. The company's net worth moved up by a moderate rise of 9.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shubham Genetics?
In 2017, Shubham Genetics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 12 Aug 2021 | ₹0.50 M | Open |
How Many Employees Work at Shubham Genetics?
Unlock and access historical data on people associated with Shubham Genetics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shubham Genetics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shubham Genetics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
